Wise plc (WPLCF)
OTC PINK OTC PINK Primary 
XDUS 
Is it Wise to Retain Alexandria Stock in Your Portfolio Now?
ARE's premium Class A/A+ properties, buyouts and solid balance sheet position bode well. A significant development pipeline and higher interest expenses pose concerns.
Is it Wise to Retain Cousins Properties Stock in Your Portfolio Now?
CUZ's Class A office assets in high-growth Sunbelt markets and rising demand for premium office space are upsides, but competition and concentration risk ail.
Is it Wise to Retain Crown Castle Stock in Your Portfolio Now?
CCI is set to gain from the rising data consumption driven by increasing digitization. Yet, customer concentration and consolidation in the industry are woes.
Is it Wise to Retain Equity Residential Stock in Your Portfolio Now?
EQR is set to gain from healthy renter demand and strategic portfolio repositioning efforts. Yet, elevated supply and high interest expenses remain concerns.
Is it Wise to Add Regency Centers Stock to Your Portfolio Now?
REG is set to gain from healthy demand for its retail assets driving leasing and rental growth. Higher e-commerce adoption and a concentrated portfolio ail.
Is it Wise to Retain UDR Stock in Your Portfolio Now?
Job growth aids high rental unit demand for UDR. A healthy balance sheet and technological moves are add-ons.
Is it Wise to Retain Public Storage Stock in Your Portfolio Now?
A high brand value in the need-based self-storage industry and strategic acquisitions are PSA's strengths. A softer demand and high-interest expenses ail.
Is it Wise to Retain SBA Communications Stock in Your Portfolio Now?
The rising adoption of data-driven devices and applications aids SBAC. High customer concentration and the ongoing consolidation in the wireless industry ail.
Is it Wise to Retain Equinix Stock in Your Portfolio Now?
Robust data center demand, expansion efforts and a healthy balance sheet are likely to aid EQIX. A competitive landscape and high interest expenses are concerns.
Why Its Not Wise to Buy the 12% YTD Drop in Halliburton Stock
HAL's Q3 adjusted EPS of 73 cents missed the Zacks Consensus Estimate of 75 cents and came below the year-ago quarter profit of 79 cents.
Is it Wise to Retain Alexandria Stock in Your Portfolio Now?
ARE's premium Class A/A+ properties, buyouts and a healthy balance sheet position bode well. A significant development pipeline poses concerns.
3 Reasons Why Buying Madrigal Pharmaceuticals Today Is a Wise Move
When a company's shares shoot up 82% in 12 months, investors clearly think it's a good time to be a shareholder -- and that's exactly what's happened to the stock of Madrigal Pharmaceuticals (MDGL 5.53%). Earlier this year, the up-and-coming biotech received approval of a pioneering liver-disease treatment.
